Ocaratuzumab (Anti-CD20)Ocaratuzumab (Anti-CD20)
Move your mouse over image or click to enlarge

Ocaratuzumab (Anti-CD20)

Ocaratuzumab (anti-CD20) is a Fc-engineered monoclonal antibody directed against human CD20 with potential antineoplastic activity. Ocaratuzumab exhibits more effective antibody-dependent cell-mediated cytotoxicity (ADCC). MW: 145.38 kD.
Cat# Size Price Qty Buy
A2969-1mg*25 1mg*25
£2,432.00
A2969-1mg*5 1mg*5
£794.00
A2969-1mg 1mg
£303.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2969

Related Documents